PDGFRA and neoplasm: The OR of c-KIT positivity, adjusted for histopathological type, grade, tumor size >20 mm, and lymph node engagement, was 6.8 times higher for TNBC cases than for non-TNBC cases (95% CI 2.9–16, P<0.001) and the corresponding adjusted OR of VEGFR2 positivity was 3.6 (95% CI 1.4–9.3, P = 0.007), and of PDGFRα positivity 1.3 (95% CI 0.6–3.1, P = 0.5).